Clinical Trial: A Study to Evaluate the Pharmacokinetic, Pharmacodynamic Characteristics and the Safety After Administration by Doses of BR1400-1, BR1400-2, BR1400-3 in Healthy Adult Volunteers

U.S., March 22 -- ClinicalTrials.gov registry received information related to the study (NCT06889064) titled 'A Study to Evaluate the Pharmacokinetic, Pharmacodynamic Characteristics and the Safety After Administration by Doses of BR1400-1, BR1400-2, BR1400-3 in Healthy Adult Volunteers' on March 17.

Brief Summary: The purpose of this clinical study is to evaluate the pharmacokinetic, pharmacodynamic characteristics and the safety after administration by doses of "BR1400-1", "BR1400-2", "BR1400-3" in healthy volunteers

Study Start Date: Sept. 24, 2024

Study Type: INTERVENTIONAL

Condition: Essential Hypertension

Intervention: DRUG: BR1400-1

One tablet administered alone

DRUG: BR1400-2

One tablet administered alone

DRUG: BR1400-3 ...